COMPASS THERAPEUTICS INC
CMPXNASDAQ🏆 #2597 by market capEarnings Nov 4US Equity
$2.21▼ $0.02 (−1.12%)
Market closed · at close1h—
24h▼ 1.1%
7d▲ 17.0%
14d▲ 13.4%
30d▼ 2.9%
1y▼ 30.4%
🏦Market Cap
$397M
Small Cap
📈Revenue Growth (YoY)
-100.0%
Declining
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
45
Weak
📊
Analyst Ratings
Price
$2.21
Total
15
Raised
2
Lowered
0
Avg PT
$10.00
H / L
$15 / $6
| Institution | Action | Rating | Date |
|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-04-28 |
Canaccord Genuity | Reiterated | Buy | 2026-04-28 |
D. Boral Capital | Reiterated | Buy | 2026-04-27 |
HC Wainwright & Co. | Reiterated | Buy | 2026-04-27 |
Guggenheim | Reiterated | Buy | 2026-03-24 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-04-02 |
Jefferies | Reiterated | Buy | 2025-02-10 |
Ladenburg Thalmann | Upgraded | Neutral → Buy | 2024-09-16 |
Wedbush | Reiterated | Outperform | 2024-08-07 |
Stifel | Reiterated | Buy | 2023-01-27 |
EF Hutton | Reiterated | Buy | 2022-12-16 |
Raymond James | Reiterated | Outperform | 2022-11-10 |
SVB Leerink | Reiterated | Outperform | 2022-05-05 |
B. Riley Securities | Reiterated | Buy | 2022-01-19 |
Roth Capital | Reiterated | Buy | 2021-11-19 |
One row per institution, most recent rating